Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Inventory Average (2019 - 2026)

Akebia Therapeutics has reported Inventory Average over the past 7 years, most recently at $17.1 million for Q4 2025.

  • Quarterly Inventory Average fell 6.76% to $17.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.1 million through Dec 2025, down 6.76% year-over-year, with the annual reading at $15.9 million for FY2025, 0.25% changed from the prior year.
  • Inventory Average was $17.1 million for Q4 2025 at Akebia Therapeutics, down from $17.7 million in the prior quarter.
  • Over five years, Inventory Average peaked at $52.9 million in Q1 2021 and troughed at $17.1 million in Q4 2023.
  • The 5-year median for Inventory Average is $21.6 million (2023), against an average of $27.8 million.
  • Year-over-year, Inventory Average crashed 62.88% in 2021 and then grew 19.58% in 2024.
  • A 5-year view of Inventory Average shows it stood at $35.2 million in 2021, then dropped by 4.99% to $33.4 million in 2022, then crashed by 48.91% to $17.1 million in 2023, then rose by 7.63% to $18.4 million in 2024, then decreased by 6.76% to $17.1 million in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Inventory Average are $17.1 million (Q4 2025), $17.7 million (Q3 2025), and $18.2 million (Q2 2025).